Diagnos Inc. has signed an agreement with Novartis Pharma AG, to continue and expand joint deployment and usage of CARA in the United Arab Emirates.
Peter Nowacki, Vice-President, Diagnos said, “Novartis\' leadership and support will make these initiatives feasible and will undoubtedly greatly benefit the local population. We are very excited with this important relationship. Under the terms of this first agreement, DIAGNOS will continue to conduct deployments within the UAE including both stationary and mobile applications for an initial amount of $100,000, with the objective to scale-up subsequently within the UAE and the Middle East. We are presently working on putting in place relationships of a similar nature in certain areas in North America, Latin America, and Asia.â€
Novartis deals in provision of healthcare solutions that address the evolving requirements of patients and societies.
DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.
Peter Nowacki, Vice-President, Diagnos said, “Novartis\' leadership and support will make these initiatives feasible and will undoubtedly greatly benefit the local population. We are very excited with this important relationship. Under the terms of this first agreement, DIAGNOS will continue to conduct deployments within the UAE including both stationary and mobile applications for an initial amount of $100,000, with the objective to scale-up subsequently within the UAE and the Middle East. We are presently working on putting in place relationships of a similar nature in certain areas in North America, Latin America, and Asia.â€
Novartis deals in provision of healthcare solutions that address the evolving requirements of patients and societies.
DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.